article thumbnail

The potential of AI in pharma R&D

Pharmaceutical Technology

According to Deloitte , 76% of biopharma companies invest in AI for clinical development. Companies that combine rapid innovation with speedy but safe trials can gain a multifaceted competitive advantage. Manufacturing Manufacturing is increasingly becoming digitized or automated, particularly in inspection and quality control.